Inulin Supplementation Mitigates Gut Dysbiosis and Brain Impairment Induced by Mild Traumatic Brain Injury during Chronic Phase

Mild traumatic brain injury (mTBI) has been shown to acutely alter the gut microbiome diversity and composition, known as dysbiosis, which can further exacerbate metabolic and vascular changes in the brain in both humans and rodents. However, it remains unknown how mTBI affects the gut microbiome in the chronic phase recovery (past one week post injury). It is also unknown if injury recovery can be improved by mitigating dysbiosis. The goal of the study is to fill the knowledge gap. First, we aim to understand how mTBI alters the gut microbiome through the chronic period of recovery (3 months post injury). In addition, as the gut microbiome can be modulated by diet, we also investigated if prebiotic inulin, a fermentable fiber that promotes growth of beneficial bacteria and metabolites, would mitigate dysbiosis, improve systemic metabolism, and protect brain structural and vascular integrity when administered after 3 months post closed head injury (CHI). We found that CHI given to male mice at 4 months of age induced gut dysbiosis which peaked at 1.5 months post injury, reduced cerebral blood flow (CBF) and altered brain white matter integrity. Interestingly, we also found that Sham mice had transient dysbiosis, which peaked 24 hours after injury and then normalized. After 8 weeks of inulin feeding, CHI mice had increased abundance of beneficial/anti-inflammatory bacteria, reduced abundance of pathogenic bacteria, enriched levels of short-chain fatty acids, and restored CBF in both hippocampi and left thalamus, compared to the CHI-control fed and Sham groups. Using machine learning, we further identified top bacterial species that separate Sham and CHI mice with and without the diet. Our results indicate that there is an injury- and time-dependent dysbiosis between CHI and Sham mice; inulin is effective to mitigate dysbiosis and improve brain injury recovery in the CHI mice. As there are currently no effective treatments for mTBI, the study may have profound implications for developing therapeutics or preventive interventions in the future.


Introduction
Approximately 1.6-3.8 million people sustain a mild traumatic brain injury (mTBI) in the US annually [1]. This amounts to the hospitalization of 100-300 per 100,000 young adults [1,2]. The Centers for Disease Control and Prevention reports that around 5.3 million people live with a permanent disability after mTBI [3], and there are currently no known restorative therapies [4].
Reduced cerebral blood flow (CBF) [5,6] and impaired white matter integrity (WMI) [7] are typical phenotypes of mTBI. Recent studies further show that mTBI significantly alters the balance of microbial communities in the gut of rodents and humans, known as gut dysbiosis [8][9][10].The effects of neurotrauma radiate to the intestine and alter the composition and diversity of the gut microbiome. This results in reduced levels of putatively beneficial bacteria which in turn leads to the reduction of short-chain fatty acids (SCFAs), bacterial metabolites that play a key role in modulating metabolism, vascular response, and inflammation system-wide [11,12]. Dysbiosis has been shown to occur in the acute phase as early as one day post injury in rodent models [9] and humans [10]. Elucidating that TBI induces dysbiosis pinpoints the gut microbiome as a potential target to protect against the secondary injury cascade known to follow TBI [13]. However, gut microbiome composition past the acute phase of mTBI (1-7 days) has yet to be characterized. This leaves a pivotal gap in the knowledge pertaining to the long-term changes in gut microbial structure after the initial injury. Further, it is unknown whether interventions that can modulate the microbiome, such as diet, could mitigate injury effects in the chronic phase.
The purpose of the study is two-fold. First, with a longitudinal study design, we determined the long-term effects of CHI on the gut microbiome, CBF, and WMI. Second, we determined if prebiotic inulin could mitigate injury-induced dysbiosis and restore CBF and WMI by modulating gut microbiome from 3 months post injury (mpi) to 5 mpi. We chose inulin because it consists of non-digestible carbohydrates that can stimulate the growth of bacteria that produce SCFAs [14,15] and enhance neuroprotection [16,17]. We expect the outcomes from the study will advance our knowledge on dysbiosis after CHI from acute to chronic phases, and the potential of dietary intervention for facilitating CHI recovery.

Experimental design
We used male C57BL/6 wild-type mice for all experiments (total N=20). Ten mice were placed in the Sham group and ten mice were placed in the closed head injury (CHI) group. Mice were singly housed throughout the study to avoid feces exchange as mice are coprophagic. Mice were administered a CHI at 4 months of age. Figure 1 shows the study design. Fecal samples were collected throughout the study at 24 hours before injury, 24 hours post injury, 1.5 mpi, 3 mpi, and 5 mpi. Before diet administration, at 3 mpi we assessed CBF and WMI (indexed by fractional anisotropy (FA)) using MRI. After this, mice were fed either a prebiotic diet containing inulin (catalog number 1817795-203) that is fermentable (Sham-Inulin, CHI-Inulin) or a control diet containing cellulose (catalog number 1817794 −203) that is nonfermentable (Sham-Control, CHI-Control) for a period of 8 weeks, or until 5 mpi (9 months of age) (n=5/group). Table 1 shows the diet composition. We fed the mice 8% inulin because 8% inulin has shown positive results on the gut microbiome and related metabolites, as well as other metrics such as brain and systemic metabolism in previous studies from our lab [14]. Inulin has a higher percentage of carbohydrates than cellulose because inulin is a fermentable fiber which means that inulin can be fermented by the gut microbiome and turned into metabolites such as SCFAs which are energy sources to the body [18]. The mice had ad libitum access to the diets, and we measured the weight of the mice and the weight of the remaining food biweekly to estimate the food intake during the feeding period. At 3 mpi we assessed CBF and FA prior to diet administration. At 5 mpi we again used multi-modal MRI metrics to assess CBF and FA. Mice were euthanized by carbon dioxide inhalation and decapitated. Cecum, blood, and brain tissues were collected thereafter for metabolomics and other biochemical analyses. All experimental procedures were performed according to NIH guidelines and approved by the Institutional Animal Care and Use Committee (IACUC) at the University of Kentucky (UK).

Closed head injury
Briefly, as previously described [19,20], mice were anesthetized with isoflurane (4-5% induction followed by 2-3% maintenance) prior to insertion of ear bars to stabilize the head in the digital mouse stereotaxic frame (Stoelting Co., Chicago, IL). A midline sagittal scalp incision was made and a 1ml latex bulb (Fisher Scientific) was placed under the head and filled with water to displace the force during impact from the ears. An electromagnetic impactor was used to deliver a single controlled mid-line cortical impact at 5.0 ± 0.2 m/s, 100 ms dwell time, and 1.0 mm impact depth. Planned exclusion criteria included depressed skull fracture or bleeding; however, no mice were excluded from the study. Sham-injured mice underwent identical surgical procedures, but no impact was delivered. Righting-reflex was recorded as an acute neurological assessment. Within one hour after injury, animals were fully conscious and able to ambulate.

Gut microbiome sequencing
Fecal samples were collected by putting each mouse in a clean autoclaved cage and waiting for it to defecate normally. Samples were collected during a 2-hour window from 7 am to 9 am. Samples were used to obtain genomic DNA. QIAGEN DNeasy PowerSoil Kit was used per manufacturers' guidelines. Shotgun metagenomic sequencing was done by CosmosID. Briefly, DNA libraries were assembled using the CosmosID proprietary library prep kit and pooled by adding an equimolar ratio of each sample on a high sensitivity chip to estimate size. Libraries were then sequenced using an Illumina Miseq platform. Unassembled reads were directly analyzed by the CosmosID bioinformatics platform (CosmosID Inc., Rockville, MD), which allows for multi-kingdom microbiome analysis, profiling of antibiotic resistance and virulence genes, and quantification of relative abundance. CosmosID uses a high-performance k-mer based algorithm that disambiguates hundreds of millions of short reads of a sample into the microorganisms that the sequences represent. Matrix tables of detected taxa were generated, and heat maps were produced. These allow for visualization of diversity and abundance of each microbial taxa.

Short chain fatty acid analysis of plasma and cecal contents
Eight SCFAs from cecum and plasma were analyzed with LCMS/MS by Metabolon Inc. (Morrisville, NC): acetic acid (C2), propionic acid (C3), isobutyric acid (C4), 2methylbutyric acid (C5), isovaleric acid (C5), valeric acid (C5), and caproic acid (C6). Both sets of samples were stable labeled with internal standards and homogenized in an organic solvent. The samples were then centrifuged followed by an aliquot of the supernatant used to derivatize to form SCFA hydrazides. This reaction mixture was subsequently diluted, and an aliquot was injected into an Agilent 1290/AB Sciex QTrap 5500 LCMS/MS system.

Data analysis
Microbiome diversity and dissimilarity analyses: Alpha diversity (within sample, Shannon index) and beta diversity (dissimilarities between samples, Bray-Curtis index) were performed in order to compare the microbial community as a whole between different sample groups (i.e. diet, injury). Data analysis and visualizations were performed by CosmosID (Rockville, MD), with Wilcoxon Rank-Sum and PERMANOVA tests. Linear Discriminant Analysis Effect Size (LEfSe) differential abundance analyses were performed between pairs of cohorts to determine taxa that are significantly enriched in each cohort.

Machine learning (ML) analysis:
To identify the bacterial species that play the pivotal role to differentiate dysbiosis at different timepoint in each group (i.e. Baseline vs. Acute in Sham and Acute vs. Mid in CHI), we performed ML analysis to rank the relative importance of the microbiota. We used the Support Vector Machine (SVM) algorithm for supervised classification and the SHapley Additive exPlanations (SHAP) to visualize the SVM prediction results. We applied 3-fold cross-validation and assess the algorithm's performance with Accuracy, F1 score, and Area Under the Curve (AUC). For SVM, we used the python function "sklearn.svm.svc" to implement the SVM with hyperparameters: C=10, gamma='auto', probability=True". For SHAP, we used the function "KernelExplainer()" for the SVM model and adopted "summary_plot" functions to visualize the SVM model predictions.

Statistical analysis
All statistical analyses were completed using GraphPad Prism 9.0 (GraphPad, San Diego, CA, USA). Two-way ANOVAs were performed for determination of differences between groups (injury type and diet effects) followed by post-hoc Welch's t-tests. Levels of statistical significance were reached when p<0.05. For the microbiome, given the multiple comparisons inherent in analysis of microbiota, between-group relative differences are assessed using both p-value and false discovery rate analysis (q-value). Figures 2A and 2B show the beta diversity at the four longitudinal timepoints of the Sham and CHI groups, respectively. We found significant difference within the Sham group between the Baseline and Acute timepoints ( Figure 2C) (Sum of Squares=0.3443181, R 2 =0.2042643, F=4.620575, p=0.003), and within the CHI group between the Acute and Mid timepoints( Figure 2D) (Sum of Squares=0.1867712, R 2 =0.127083, F=2.620517, p=0.011). Figure 3A shows the top 10 microbiota ranked by ML algorithm that can separate dysbiosis status at the Baseline from Acute timepoint in the Sham group. The ML performance was robust with 84.9% accuracy, 84.6% F1 score and 88.9% AUC. Compared to the Baseline, we found that Acute timepoint had decreases in beneficial bacteria such as Akkermansia muciniphila and increases in bacteria such as Firmicutes bacterium ASF500 (Table 2).

Bacterial species differentiate dysbiosis under Sham and CHI at different timepoints
Similarly, Figure 3B shows the top 10 microbiota ranked by ML algorithm that can separate dysbiosis status at the Acute from Mid timepoint in the Sham group. The ML performance was also robust with 75.9% accuracy, 74.7% F1 score and 85.6% AUC. Compared to the Acute phase, we found that the Mid timepoint had decreases in beneficial bacteria such as Lactobacillus johnsonii, and increases in species from the Lachnospiraceae family, which is known to be associated with various disease states, such as Lachnospiraceae bacterium A2, 28-4 and A4. Table 2 shows the relative abundance of the species in the importance table for each timepoint, with lower values shaded in gray.

CHI mice show decreased CBF and changes in FA compared to Sham mice
CBF and FA were measured 3 mpi. CBF was shown to be lower in the CHI group compared to the Sham group in the left ( Figure 4A) and right proximal cortex ( Figure 4B). There are higher levels of FA in the left ( Figure 4C) and right fimbria ( Figure 4D) compared to the Sham group and lower levels of FA in the right external capsule ( Figure 4E) compared to the Sham group. Changes in FA fit with the literature which indicates that decreased FA is expected after injury, but FA can also be increased after injury potentially due to compensatory mechanisms or edema [25].

Inulin altered gut microbial diversity in both Sham and CHI mice
After two months of inulin feeding at the chronic phase, we found that alpha diversity was reduced in both the Sham and CHI groups (p<0.05) ( Figure 5A). Similarly, inulin significantly altered beta diversity in the Sham ( Figure 5B) (Sum of Squares=0.3417861, R 2 =0.2355275, F=2.464733, p=0.038) and CHI groups ( Figure 5C) (Sum of Squares=0.4846131, R 2 =0.3702754, F=4.703967, p=0.012) using the Bray-Curtis index.

Inulin altered gut microbiome at the phylum level predominately in the CHI mice
At the phylum level, we found that in the CHI group, inulin increased Verrucromicrobia (p=0.0008) ( Figure 6A), and Actinobacteria (p=0.0359) ( Figure 6B) but decreased Firmicutes (p=0.0102) ( Figure 6C) compared to the CHI control mice. Inulin significantly increased Proteobacteria in the Sham group (p=0.0178) but not the CHI group (p=0.0590) ( Figure 6D). No significant differences of Bacteroidetes were found between the control and inulin diet in both CHI and Sham groups (Sham control vs. inulin p=0.1978; CHI control vs. inulin p=0.2691). The distribution of the relative abundance of the five phyla is shown in Figure 6E.

Inulin increased SCFA-producing bacteria and reduced pathogenic bacteria in CHI mice
Using LEfSe analysis, we determined taxonomic similarities and differences between Sham ( Figure 7A) and CHI mice ( Figure 7B) at the species level. The control diet selected for species in the CHI and Sham groups including the Lachnospiraceae family and Clostridium and Clostridioides genera, as well as other species such as Dorea sp. 5-2 and Oscillibacter sp. 1-3. However, the species selected for inulin differ between the Sham and CHI groups. In the CHI group, but not the Sham group, inulin promoted several bacteria that have a positive effect on the gut and produce beneficial metabolites such as SCFAs including Bifidobacterium species (animalis, AGR1258, pseudolongum) and Akkermansia muciniphila.
The major changes at the species levels are summarized in Figure 8. Based on the LEfSe analysis, we found that inulin increased putatively beneficial bacteria ( Figure 8A) and decreased pathobiont bacteria ( Figure 8B). Compared to the control diet, the inulin diet decreased Dorea sp. 5-2 and Oscillibacter sp. 1-3, which have both been positively correlated with intestinal permeability [26,27]; Clostridium clostridioforme, which is associated with bacteriemia [28]; and Clostridioides difficile, a pathobiont [29]. Inulin also decreased Lachnospiraceae spp. (including L. bacterium 3-2, L. bacterium A2, L. bacterium 10-1, L. bacterium 28-4, and L. bacterium COE1) which have been implicated in colitis [30] and metabolic disorders [31]. Inulin increased Bifidobacterium pseudolongum, a SCFA producer, Bifidobacterium animalis and Bifidobacterium sp. AGR2158, which fits with the literature indicating inulin as a bifidogenic fiber [32]. It also increased Akkermansia muciniphila, which is also a SCFA producer [33]. Lactobacillus johnsonii does show a decrease in the CHI group, but this is likely due to out-competition from Bifidobacterium spp. and A. muciniphila.

Inulin increased cecal and serum SCFA levels in the CHI and Sham mice
In the cecum SCFA analysis, most notably, the inulin-fed groups (Sham and CHI) showed significant increases in acetic acid (Sham p<0.0001; CHI p=0.0032) ( Figure 9A), propionic acid (Sham p=0.0070; CHI p=0.0024) ( Figure 9B), and butyric acid (Sham p=0.0009; CHI p=0.0193) ( Figure 9C) compared to the control fed groups. In the serum, only acetic acid was found significantly different between the CHI-control and CHI-inulin mice (p=0.0385) ( Figure 9D).

Discussion
To our knowledge, our study is the first to characterize the gut microbiome in the chronic phase (past one week post CHI) [34,35]. We further showed that CBF and WMI of CHI mice were impacted in the acute phase but normalized to a level similar to that of the Sham mice in the chronic phase. We summarized our findings in Figure 11. It shows that despite the CHI-induced dysbiosis, prebiotic inulin was able to increase the level of beneficial bacteria, reduce pathobiont bacteria, and elevate SCFAs in the cecal contents and plasma. Inulin also restored CBF in both hippocampi and the left thalamus. Inulin may mitigate long-term effects of mTBI due to positive effects on the gut microbiome.
An interesting finding from the study is that the Sham mice also showed dysbiosis at different timepoint compared with the CHI mice. This is unexpected based upon data from previous studies [36]. Sham mice showed dysbiosis at the Baseline-Acute phase, while CHI mice showed dysbiosis at the Acute-Mid phase. The top three species that classify Baseline vs. Acute timepoints in the Sham group were decreased Akkermansia muciniphila, increased Firmicutes ASF500, and decreased Dorea sp. 5-2. Decreased Akkermansia muciniphila has been observed in patients with ulcerative colitis and other metabolic disorders, indicating its potential anti-inflammatory properties [37]. Increases are seen in Firmicutes ASF500 levels with excess manganese exposure, which is neurotoxic and can lead to Alzheimer's and Parkinson's Disease [38]. Decreased levels of Dorea sp. 5-2 are beneficial as this species is associated with intestinal permeability [26], indicating the possible transient nature of dysbiosis in the Sham group. Although there was some dysbiosis (increased ASF500, decreased Akkermansia muciniphila), there was also some recovery (decreased D. sp. 5-2). As for the CHI group, between the Acute to Mid timepoint, the most important feature was the increased Lachnospiraceae bacterium A2. The Lachnospiraceae family is associated with colitis [30] and metabolic disorders, such as Type 2 Diabetes, metabolic syndrome, and glucose metabolism disorders [31]. Another top feature was decreased Lactobacillus johnsonii, which has probiotic properties such as immunomodulation and pathogen inhibition. Therefore, its decrease could be indicative of a dysbiotic state [39].
With diet, we found significant decreases in alpha diversity in the inulin-fed mice compared to the control-fed mice, in both Sham and CHI groups. It is likely due to inulin serving as a dominant energy source and selecting for a limited number of putatively beneficial bacteria, and an overall reduction in alpha diversity. This is similar to what we observed in a previous study [14]. At species level, we observed that inulin decreased putatively harmful bacteria compared to the mice fed the control diet. Dorea sp. 5-2 and Oscillibacter sp. 1-3 have both been shown to be positively correlated with intestinal permeability [26,27] and are reduced with inulin supplementation. Inulin also showed decreased Lachnospiraceae spp. compared to the control diet, which is associated with various disease states [31]. Along with this, inulin decreased levels of Clostridioides difficile, a common opportunistic nosocomial infection that blooms when the gut is in a dysbiotic state, such as after antibiotic administration [29]. We speculate that the dysbiotic state of the gut microbiome following CHI allowed for C. difficile to bloom, but inulin, which increased bacteria with anti-pathogenic qualities, such as Bifidobacterium pseudolongum, then decreased its levels [14].
The putatively beneficial bacteria such as Akkermansia muciniphila and Bifidobacterium pseudolongum are known to be anti-inflammatory in nature, as both are producers of SCFAs --B. pseudolongum produces butyrate while Akkermansia muciniphila produces acetate -both of which were increased in CHI mice fed inulin [12]. Butyrate and other SCFAs may be able to inhibit C. difficile overgrowth by causing the bacteria to lose viability [40,41]. As we see increased SCFAs and decreased C. difficle in inulin-fed mice, this could be a possible protective mechanism of inulin supplementation from increased C. difficile levels after injury. It is also known that a low abundance of Akkermansia muciniphila favors the inflammatory process [33], and we saw a much lower abundance of this bacteria in the control-fed CHI group compared to the inulin-fed CHI group. The increased levels of Akkermansia muciniphila in the inulin group is also consistent with the literature in that this species thrives on fiber [33].
We found decreased white matter integrity (indexed by FA) in the chronic phase of CHI. FA was lower in the external capsule, which is the route for cholinergic fibers from the forebrain to the cerebral cortex [42]. Higher FA values were seen in the fimbria, which is the major output tract of the hippocampus, where damage can cause difficulty in long term recall [43]. This is possibly due to a neuroplastic response to injury because compensatory mechanisms are most active during the acute and subacute periods of injury [25]. However, these higher values could also be due to axonal swelling and edema in the brain [25]. Interestingly, at 5 mpi, we did not see the FA difference between the Sham control vs. CHI control group that we saw at 3 mpi. (see Figure 4), which may indicate a normalization of white matter structure. This fits with the literature that FA typically recovers between the acute and subacute periods of injury recovery [44].
Similar to the pattern found in FA, we also observed that CBF decreased at 3 mpi, but normalized at 5 mpi, in the CHI mice compared with the Sham mice. The decreased CBF was found in the proximal cortex on the right and left side, which is the area adjacent to the injury.
Nonetheless, inulin supplementation in CHI mice restored CBF to Sham levels in the left side of the thalamus and the left and right sides of the hippocampus. The thalamus plays an important role in relaying sensory and motor signals and regulates consciousness and alertness. This is consistent with a recent study showing that supplementation with a diet rich in fruit and vegetables attenuated neuromotor and sensorimotor functions following TBI [45]. It is also possible that inulin influenced CBF through increased SCFAs. As shown, there were increases in SCFAs with inulin supplementation, butyrate and propionate in the cecum and acetate in the cecum and blood. SCFAs are known to increase tight junction proteins in the gut and brain which leads to less permeable barriers [12]. A less permeable blood-brain barrier due to increased tight junction protein expression is protective of blood flow [46]. The gut microbiome is directly related to this, as Bifidobacterium pseudolongum is a butyrate producer and Akkermansia muciniphila is an acetate producer. Both were increased with inulin supplementation [32]. Previous studies from our lab are indicative of this as well [46]. A ketogenic diet given to young healthy mice increased CBF compared to the control diet and showed similarities in the gut microbiome to our study with decreased Clostridium spp. and Dorea spp. and increased Akkermansia muciniphila [46] . Dorea spp. and Clostridium spp. are both known to increase intestinal permeability [26,47] whereas Akkermansia muciniphila is known to protect the gut barrier and produces SCFAs which are also protective of the blood brain barrier, and ultimately CBF. Together, changes in abundance of these three species may facilitate protection of neurovascular functions and may be indicative of why we saw a restoration of CBF after CHI.
This study explores changes in the gut microbiome past the acute phase of injury and sheds new light onto the chronic phase of injury recovery. Even when administered three months post injury, inulin's effects still had a positive impact on recovery through attenuating harmful effects caused by CHI in the gut microbiome, systemic metabolism, and brain vascular and structural function. This is in line with previous findings that protecting brain metabolism is important to mitigate CNS injury and age-related neurodegenerative disorders [6,[48][49][50][51][52][53][54][55]. In the future, we could also use other MRI neuroimaging methods to determining brain metabolic and vascular functions that may be influenced by inulin, including levels of essential brain metabolites [56], cerebral metabolic rate of oxygen [57,58], and cerebral blood volume [59].
A limitation of the study is that we only used male mice because men are more likely to avoid treatment or not report the head injury at all, contributing to the high number of undiagnosed injuries [60]. In the future studies, we will include female mice and further identify the potential sex-differences in response to the diet. We will also include analyses to understand how inulin is exerting its effects on a molecular level. Additionally, the Sham injury causing transient changes in the gut microbiome indicates the importance of including a naïve cohort in injury studies that aim to better understand changes in the gut microbiome. It is the standard in mTBI research to use Sham mice as a control group, however this study proves that naïve mice are needed to properly assess effects of injury.
In summary, we found that CHI induces dysbiosis and alterations in WMI and CBF through the chronic phase of injury. Additionally, we found that inulin supplementation exerted a beneficial effect on the gut microbiome which in turn led to beneficial influence systemically, most pertinently on SCFAs levels in the cecal contents and plasma, and CBF in hippocampus and thalamus in mice with chronic CHI. As there are currently no effective treatments for mTBI, the study may have profound implication for developing therapeutics or preventive interventions in the future. MANGO software developed by the Research Imaging Institute of the University of Texas Health Science Center at San Antonio. We thank Andrew Yackzan, Kelly Roberts, and Sydney Sun for assisting with experiments. We thank Tom Dolan for the illustration used in Figure 11. Figure 1: Study design.

Funding
CHI was administered at 4 months of age. Diet was started 3 mpi (7 months of age) and fecal samples were taken periodically throughout the study starting 24 hours prior to injury and ending 5 mpi. CBF and FA were analyzed at 3 mpi and 5 mpi. Cecal contents and plasma were collected at time of sacrifice. Yanckello     showed that CHI inulin fed mice had a significantly different diversity than CHI control fed mice, (Sum of Squares=0.4846131, R 2 =0.3702754, F=4.703967, p=0.012).  Analysis at the species level of CHI control versus CHI inulin fed mice. Analysis was conducted using Linear discriminant analysis Effect size (LEfSe). Control-fed CHI or Sham mice are shown in peach and inulin-fed CHI or Sham mice are shown in teal. Bars indicate that a specific species was found to be significantly increased with the diet specified. All shown are statistically significant (p ≤ 0.05) (LDA ≥ 2.0).  Comparison of relative abundance from ranked microbial species in Figure 4. Lower values are shaded in gray.